Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BMI-135 |
Synonyms | |
Therapy Description |
BMI-135 is a selective human ER partial agonist (ShERPA), potentially resulting in increased apoptosis and decreased cell proliferation (PMID: 32788222). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BMI-135 | BMI135|BMI 135 | BMI-135 is a selective human ER partial agonist (ShERPA), potentially resulting in increased apoptosis and decreased cell proliferation (PMID: 32788222). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|